- Enrolling by invitation
Long-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical Trials
This study looks at the long-term effects of AvenCell's CAR-T cell treatments for blood cancers like lymphoma and leukemia, and also prostate cancer. It checks how safe and effective these treatments are over time for people who've already had them in past AvenCell trials.
For: B-cell Lymphoma · Chronic Lymphocytic Leukemia · Hematologic MalignancyGermany - RecruitingPHASE1, PHASE2
Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies
This study tests a new 'off-the-shelf' CAR-T cell therapy, Allo-QuadCAR01-T, for hard-to-treat B-cell cancers like lymphoma. It uses donor cells that target two cancer markers, aiming to be faster and potentially more effective than current treatments. Researchers will check its safety and how well it works.
For: Lymphoma Diffuse Large B-cell · Leukemia and Lymphoma · Leukemia RelapseUnited States · Germany